New diabetes clinical trial: A Phase III RCT to Investigate the Efficacy and Safety of NW Low-Glu® in Patients With Type II Diabetes Mellitus

Published on: November 19, 2023 at 11:00PM
Conditions: Diabetes Mellitus, Type 2
Interventions: Dietary Supplement: NW Low-Glu®; Drug: Metformin
Sponsors: Natural Wellness Egypt
Not yet recruiting
https://ift.tt/kboYRFy